SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-151956
Filing Date
2016-10-25
Accepted
2016-10-25 16:43:16
Documents
1
Period of Report
2016-10-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 18532
  Complete submission text file 0001104659-16-151956.txt   20079
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Issuer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VITAE PHARMACEUTICALS, INC. 502 WEST OFFICE CENTER DR. FORT WASHINGTON PA 19034
Business Address
Gregg Richard (Reporting) CIK: 0001619574 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36617 | Film No.: 161950801